Search

A recent study conducted by investigators from Duke University focused on sepsis, a serious condition caused by bacterial bloodstream infections (BSIs). The researchers aimed to identify specific host responses to different pathogens and antibiotic treatments in patients with bacterial BSI. RNA sequencing was performed on blood samples from patients with gram-negative (GN) or gram-positive (GP) pathogens. The study found that patients with GN BSI had increased activation of the classic complement system, while patients with methicillin-resistant Staphylococcus aureus (MRSA) had reduced host transcriptional signatures involving mitochondrial energy transduction. These findings may provide insights into the persistence of MRSA compared to other bacterial BSIs. [Extracted from the article]

A recent report discusses the development and characterization of platelet membrane-derived nanodiscs (PLT-NDs) as platelet decoys for biological neutralization. These nanodiscs effectively bind with anti-platelet autoantibodies, preventing them from interacting with platelets. In mouse models, PLT-NDs successfully neutralize pathological anti-platelet antibodies and bacterial virulence factors, leading to significant survival benefits. The study highlights the potential of PLT-NDs as a promising platelet mimicry for neutralizing various biological agents that target platelets. [Extracted from the article]

A recent study conducted by researchers at Alma Mater Studiorum - University of Bologna in Italy focused on the effectiveness of ceftobiprole, a fifth-generation cephalosporin, in treating staphylococcus infections. The study used population pharmacokinetic analysis to assess the current dosages of ceftobiprole and conducted Monte Carlo simulations to determine the probability of target attainment. The research found that the standard dosages administered by continuous infusion were optimal for achieving the desired target against methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with preserved renal function. However, intensified dosages administered by continuous infusion were necessary for patients with impaired renal function and/or augmented renal clearance against MRSA and for patients with preserved renal function against Staphylococcus epidermidis (MRSE). [Extracted from the article]

Researchers from Third Military Medical University in Chongqing, China have discovered a novel compound called HL-J6 that shows promise in fighting methicillin-resistant Staphylococcus aureus (MRSA) infections. MRSA is difficult to treat due to its multi-drug resistance and ability to form biofilms, which protect it from antibiotics and the immune system. HL-J6 was found to inhibit MRSA strains and effectively kill bacteria in biofilms. It also reduced the secretion of alpha-toxin, a major virulence factor. These findings suggest that HL-J6 could be a potential lead compound for the development of new drugs against MRSA biofilm infections. [Extracted from the article]

A recent study conducted by researchers at Hamadan University of Medical Sciences in Iran explored the use of ampicillin-loaded poly (lactic-co-glycolic acid) nanoparticles conjugated with lysostaphin to prevent the formation of biofilms by methicillin-resistant Staphylococcus aureus (MRSA). The researchers created nanodrug carriers using a double emulsion evaporation technique and measured various physicochemical attributes of the nanoparticles. They found that the nanodrug carrier had a greater hindering effect on biofilm formation compared to the free drug after 72 hours. Additionally, the synthesized nanodrug showed no toxic effects on cells. The researchers suggest that this technology could be beneficial in managing staphylococcal infections caused by hospital-acquired infections. [Extracted from the article]

A report from the Second Military Medical University in Shanghai, China, discusses the development of copper-containing nanoparticles-loaded silicene nanosheets for wound healing. These nanosheets have triple enzyme mimicry activities and a photothermal effect, which contribute to efficient bacterial elimination, angiogenesis promotion, and accelerated wound healing. The nanosheets exhibit high antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and also demonstrate biocompatibility for promoting cell proliferation and angiogenic differentiation. The research suggests that these nanosheets could be a promising strategy for bacteria-invaded wound healing. [Extracted from the article]

A recent study conducted in Egypt investigated the population structure, resistome, and virulome of Methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered from hospital settings. The study found that the community-acquired MRSA lineage, clonal complex 1 (CC1), was the most frequently detected clone, followed by three other globally disseminated clones. Most isolates demonstrated multi-drug resistant phenotypes, including resistance to linezolid, a last resort antibiotic. The study also revealed a high pool of antimicrobial resistance determinants and virulence-related genes in CC1, indicating a broad public health risk. The findings of this study can be used to develop strategies for controlling MRSA infections in Egyptian healthcare settings. [Extracted from the article]

A study conducted at Saint Vincent Hospital in Worcester, Massachusetts, has found that nasal methicillin-resistant Staphylococcus aureus (MRSA) culture screens are less reliable when decolonization with ethyl alcohol has already been administered. The study aimed to determine the reliability of the nasal MRSA culture screen in guiding antibiotic deescalation. The results showed that the negative predictive value (NPV) of the nasal MRSA culture screen was compromised by universal decolonization practices, leading to false-negative results and inappropriate antibiotic deescalation. The researchers concluded that nasal MRSA culture screens are less accurate than PCR tests and should not be used as a reliable tool for antibiotic deescalation in the presence of alcohol decolonization. [Extracted from the article]

A recent study conducted at the National Research Centre in Cairo, Egypt, focused on the development of new compounds to combat Multi-Drug-Resistant (MDR) strains of Methicillin-Resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (PA). The researchers synthesized quinoline compounds and tested their antimicrobial activity against these bacteria. They found that two compounds showed the highest antimicrobial activity against PA, while two other compounds exhibited significant inhibition activity against MRSA and PA. Molecular modeling and simulations were used to determine the mode of action for the antimicrobial effect. The study also investigated the electrochemical properties of the compounds using density-functional theory (DFT) calculations. [Extracted from the article]

A patent has been issued for a new type of bacteriophage lysin called ClyS, which has been developed to target Staphylococcus aureus bacteria. S. aureus is a pathogen that causes various infections in humans and the emergence of drug-resistant strains, such as MRSA, is a major concern. Bacteriophage lysins are antimicrobial agents that can degrade the cell wall of susceptible bacteria and cause cell lysis. ClyS is unique because it combines the catalytic domain of one lysin with a binding domain from another, and it does not contain a domain that may lead to resistance. ClyS may have potential for both treatment and diagnostic purposes. [Extracted from the article]

A recent report from the Federal University of Sao Paulo highlights the alarming antimicrobial resistance scenario of community-onset methicillin-resistant Staphylococcus aureus (CA-MRSA) causing skin and musculoskeletal infections. The study analyzed MRSA isolates recovered from patients with these infections and found a high level of multidrug resistance, including resistance to beta-lactam and quinolone antibiotics. The research emphasizes the need for alternative treatment options for patients with these types of infections, as commonly prescribed antibiotics are becoming less effective. [Extracted from the article]

A recent study conducted by researchers from Mahasarakham University focused on the antibiofilm and antibacterial activities of lupinifolin, a compound derived from Derris reticulata Craib stem, in combination with protein synthesis inhibitors against methicillin-resistant Staphylococcus aureus (MRSA). The study found that lupinifolin and tetracycline significantly reduced MRSA biofilm formation, while streptomycin and clindamycin tended to enhance biofilm formation. The combination of lupinifolin and streptomycin exhibited synergy in inhibiting MRSA biofilm formation, while the combination of lupinifolin and tetracycline or clindamycin did not show any interaction. These findings suggest that lupinifolin has the potential to enhance antibiofilm activity and reduce MRSA biofilm formation. [Extracted from the article]

A study conducted by researchers at University Malaysia Sabah has found that a combination of commercial Garcinia mangostana L. (GML) extract and amoxicillin can reverse bacterial resistance in methicillin-resistant Staphylococcus aureus (MRSA). The researchers analyzed the phytochemical properties of the GML extract and detected the presence of alpha-mangostin. They conducted minimum inhibitory concentration (MIC) and checkerboard assays to assess the antibacterial activity of the GML extract with amoxicillin. The study concluded that the combination of GML extract and amoxicillin could potentially increase the susceptibility of traditional drugs. [Extracted from the article]

Researchers at the University of Calabar have conducted a study on methicillin-resistant Staphylococcus aureus (MRSA), a bacterial infection that is becoming increasingly common and poses a serious threat to human health. The study used the density functional theory (DFT) approach to examine the biological activities of thiophene- and thiazole-containing carbohydrazides. The results showed that compound 6G exhibited superior biological activity and reactivity, as well as higher binding affinities for MRSA. The study suggests that compounds 6F and 6G have potential for tackling MRSA. [Extracted from the article]

A recent study conducted by researchers at the College of Veterinary Medicine in Stillwater, Oklahoma, explored the use of thermally sensitive liposomes combined with focused ultrasound to treat methicillin-resistant Staphylococcus aureus (MRSA) bone infections. The researchers prepared ciprofloxacin-laden liposomes and implanted them into rats with MRSA-infected femurs. They found that the combination of liposomes and ultrasound significantly reduced the MRSA load in the bones compared to the control groups. This study suggests that focused ultrasound combined with thermally sensitive liposomes could be an effective treatment for hard-to-treat MRSA biofilms in bone infections. [Extracted from the article]

A study conducted by researchers at Charite - University Medicine Berlin explores the use of bacteriophage therapy in the treatment of difficult-to-treat infections. Bacteriophages are viruses that can selectively kill bacteria and can be combined with antibiotics. The study included eight patients with complex orthopedic and cardiovascular infections who were unable to undergo standard treatment. The results showed that bacteriophage therapy may be a valid additional approach when standard treatment is not feasible, with five out of six patients being infection-free after one year. Further research is needed to determine the optimal administration route, concentration, duration of treatment, and combination with antimicrobials. [Extracted from the article]

A study conducted at Chungnam National University Sejong Hospital in South Korea compared the clinical characteristics and outcomes of patients with native joint septic arthritis (NJSA) caused by methicillin-resistant Staphylococcus aureus (MRSA) versus methicillin-sensitive S. aureus (MSSA). The study found that patients with MRSA had a higher prevalence of nosocomial infections and received inappropriate antibiotics more frequently. The MRSA group also had a higher rate of overall treatment failure, including a greater need for repeated surgical interventions. The study concluded that methicillin resistance is an independent risk factor for treatment failure in NJSA cases, highlighting the importance of monitoring and targeted interventions in MRSA-related NJSA cases. [Extracted from the article]

A study conducted at the 37-Military Hospital in the Accra Metropolis, Ghana, found a higher prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among diabetic patients compared to non-diabetic patients. The study suggests that the constant use of antibiotics as prophylactics for foot ulcers in diabetic patients may contribute to the development of antibiotic resistance. The researchers collected samples from both diabetic and non-diabetic patients and found that antibiotic resistance was significantly higher among diabetic patients. This information highlights the importance of implementing best practices to minimize the adverse effects of antibiotic resistance. [Extracted from the article]

A study conducted at Helwan University in Cairo, Egypt, aimed to characterize the biofilm matrix composition of a newly described Staphylococcus aureus biofilm phenotype. The study analyzed methicillin-resistant and methicillin-susceptible Staphylococcus aureus biofilm-forming clinical isolates under two different culture conditions. The efficacy of two antibiofilm drugs, Cis-2-Decenoic acid and hamamelitannin, was evaluated on the biologically-relevant biofilms. The research concluded that applying biologically-relevant culture conditions to staphylococci biofilms and antibiofilm drugs is recommended. [Extracted from the article]

A recent research report from the University of Santo Tomas Hospital discusses a case of a rare and potentially serious condition called spinal epidural abscess caused by methicillin-resistant Staphylococcus aureus (MRSA). The report describes the case of a 21-year-old Filipino female who presented with symptoms including fever, severe neck and upper back pain, and numbness and weakness in the lower extremities. The patient underwent surgery and received an 8-week course of antibiotics, which led to an improvement in symptoms. This is the first reported case of extensive spinal epidural MRSA abscess in a Filipino individual without HIV. [Extracted from the article]

A recent study conducted by researchers from the University of New Mexico Hospitals examined the outcomes of intermittent infusion (IIV) versus continuous infusion (CIV) of vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. The study found that patients on CIV were able to achieve the therapeutic goal significantly faster than those on IIV. Additionally, patients who were unable to achieve a therapeutic trough on IIV became therapeutic once switched to CIV. The study also compared the frequency of adverse drug reactions between the two methods of administration. The research provides valuable insights into the effectiveness of different infusion methods for treating MRSA bacteremia. [Extracted from the article]

Researchers at Ohio State University have conducted a study on the use of methicillin-resistant Staphylococcus aureus (MRSA) nasal screens to rule out MRSA pneumonia in surgical intensive care units (ICUs). The study found that the MRSA polymerase chain reaction (PCR) has a high negative predictive value (NPV) for ruling out MRSA pneumonia in critically ill surgical patients. However, patients in the cardiothoracic/cardiovascular ICU (CVICU) and patients hospitalized for five or more days had a longer time to de-escalation of MRSA-targeted therapy, potentially due to a higher clinical risk profile. The study provides valuable insights into the use of MRSA nasal screens in ICU settings. [Extracted from the article]

A report from the University of Bern in Switzerland discusses the virulence attributes of successful methicillin-resistant Staphylococcus aureus (MRSA) lineages. MRSA is a leading cause of severe and often fatal infections, and its epidemics have been characterized by the replacement of previously successful lineages with more fit and better adapted ones. The review focuses on the mechanisms that contribute to the establishment and maintenance of dominant MRSA lineages globally, with an emphasis on factors that influence colonization and disease-causing abilities within a host. The research suggests that understanding how specific MRSA clones cause prolonged epidemics may lead to the development of therapies that target both core and acquired virulence factors. [Extracted from the article]

A recent study conducted by researchers at the University of Aveiro in Portugal explores the use of antimicrobial photodynamic therapy (aPDT) as an alternative to traditional antibiotics for combating methicillin-resistant Staphylococcus aureus (MRSA). The study focuses on the effectiveness of two b-modified monocharged porphyrin-imidazolium derivatives in polyvinylpyrrolidone (PVP) formulations and graphitic carbon nitride materials. The results show that both formulations demonstrated excellent performance in photoinactivating MRSA, with the PVP formulation requiring 10 minutes of exposure to white light and the graphitic carbon nitride hybrid requiring 20 minutes. These findings suggest the potential of these materials for use in clinical and environmental settings, offering a solvent-free and recoverable treatment option for bacteria photoinactivation. [Extracted from the article]

A recent study conducted at the First Affiliated Hospital of Bengbu Medical College examined the benefits of single-room management in an intensive care unit (ICU) for preventing hospital-acquired infections. The study analyzed the prevalence of pathogenic bacterial infections and changes in drug resistance among major pathogens from 2016 to 2020. The results showed a decreasing trend in the ratio of pathogenic bacteria to the number of beds each year. The introduction of single-room wards was found to reduce the presence of multi-drug resistant bacteria. The study concluded that single-room management in ICUs can effectively reduce the risk of cross-infection without adverse effects. [Extracted from the article]

A recent study published in Drug Week explores the mechanisms behind high-level, broad-spectrum beta-lactam resistance in Staphylococcus aureus, a leading cause of mortality worldwide. The study focuses on Methicillin-Resistant Lacking mec (MRLM) strains of S. aureus, which exhibit resistance to Next Generation beta-lactams (NGBs) despite lacking the mecA gene typically associated with resistance. The researchers found that mutations in the PBP4 and GdpP proteins, commonly found in MRLM strains, work together to mediate NGB resistance. These findings challenge current understanding and suggest a need for reevaluating the diagnosis and treatment of beta-lactam resistant S. aureus infections. [Extracted from the article]

A recent study conducted at the University of Missouri Kansas City has explored new findings in antibiotics. The researchers used a multidimensional chemical library screening strategy to identify compounds with anti-methicillin-resistant Staphylococcus aureus (MRSA) activity. They screened a library of compounds in both their original and metabolized forms, as well as in the presence of cefoxitin, an antibiotic. The study identified several compounds with significant synergy with cefoxitin and three potential folate/thymidine biosynthesis inhibitors. These findings highlight the importance of library screening in the search for new antibacterial agents to combat antimicrobial resistance. [Extracted from the article]

A recent study conducted at Rashtrasant Tukadoji Maharaj Nagpur University in India focuses on Staphylococcus aureus, a common human pathogen that poses therapeutic challenges due to its resistance to antibiotics. The study explores the mechanism of resistance in methicillin-resistant Staphylococcus aureus (MRSA) and the need for novel antibiotics. Specifically, the study reviews different compounds and their biological activities as potential inhibitors of the penicillin-binding protein 2a (PBP2a), a crucial target in the MRSA cell wall. The research also discusses various aspects of PBP2a, bacterial cell walls, and future perspectives on MRSA inhibitors. [Extracted from the article]

A recent study conducted at King Saud University in Saudi Arabia has reported promising results in the fight against Methicillin-resistant Staphylococcus aureus (MRSA). The researchers developed an engineered enzybiotic called BAC100, which was found to resensitize MRSA to conventional antibiotics. When used in combination with ampicillin and tetracycline, BAC100 was able to significantly reduce live MRSA cells. This study is one of the first to demonstrate the potential of engineered enzybiotics in combating antibiotic-resistant pathogens and may lead to the development of similar peptides for clinical use. [Extracted from the article]

According to news originating from Riyadh, Saudi Arabia, by NewsRx correspondents, research stated, "The methicillin-resistant Staphylococcus aureus (MRSA) was designated as a high-priority pathogen by the World Health Organization. Keywords: Amides; Antibiotics; Antimicrobial Resistance; Bacillales; Beta-Lactam Antibiotics; Beta-Lactam Resistance; Drug Resistance; Drugs and Therapies; Emerging Technologies; Endospore-Forming Bacteria; Foodborne Diseases and Conditions; Gram-Positive Bacteria; Gram-Positive Cocci; Gram-Positive Endospore-Forming Rods; Health and Medicine; Hematology; Hemolytic; MRSA; Methicillin Resistance; Methicillin Therapy; Methicillin-Resistant Staphylococcus aureus; Nanoparticles; Nanotechnology; Organic Chemicals; Penicillin Resistance; Penicillins; Pharmaceuticals; Staphylococcaceae; Staphylococcus; Staphylococcus aureus; Therapeutics; Therapy EN Amides Antibiotics Antimicrobial Resistance Bacillales Beta-Lactam Antibiotics Beta-Lactam Resistance Drug Resistance Drugs and Therapies Emerging Technologies Endospore-Forming Bacteria Foodborne Diseases and Conditions Gram-Positive Bacteria Gram-Positive Cocci Gram-Positive Endospore-Forming Rods Health and Medicine Hematology Hemolytic MRSA Methicillin Resistance Methicillin Therapy Methicillin-Resistant Staphylococcus aureus Nanoparticles Nanotechnology Organic Chemicals Penicillin Resistance Penicillins Pharmaceuticals Staphylococcaceae Staphylococcus Staphylococcus aureus Therapeutics Therapy 3326 3326 1 11/06/23 20231110 NES 231110 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on methicillin-resistant Staphylococcus aureus have been presented. [Extracted from the article]

Keywords: Mexico City; Mexico; North and Central America; Amides; Antibacterials; Antibiotics; Antimicrobials; Bacillales; Beta-Lactam Antibiotics; Beta-Lactam Resistance; Cephalosporins; Drug Resistance; Drugs and Therapies; Endospore-Forming Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Gram-Positive Endospore-Forming Rods; Health and Medicine; Methicillin Resistance; Methicillin Therapy; Organic Chemicals; Penicillin Resistance; Penicillins; Pharmaceuticals; Staphylococcaceae; Staphylococcus; Staphylococcus aureus; Sulfur Compounds; Thiazines EN Mexico City Mexico North and Central America Amides Antibacterials Antibiotics Antimicrobials Bacillales Beta-Lactam Antibiotics Beta-Lactam Resistance Cephalosporins Drug Resistance Drugs and Therapies Endospore-Forming Bacteria Gram-Positive Bacteria Gram-Positive Cocci Gram-Positive Endospore-Forming Rods Health and Medicine Methicillin Resistance Methicillin Therapy Organic Chemicals Penicillin Resistance Penicillins Pharmaceuticals Staphylococcaceae Staphylococcus Staphylococcus aureus Sulfur Compounds Thiazines 1361 1361 1 11/06/23 20231110 NES 231110 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on Gram-Positive Bacteria - Staphylococcus aureus is the subject of a report. For more information on this research see: Qsar Analysis of Five Generations of Cephalosporins To Establish the Structural Basis of Activity Against Methicillin-resistant and Methicillin-sensitive staphylococcus Aureus. [Extracted from the article]

Keywords: Amides; Antibacterials; Antibiotics; Antiinfectives; Beta-Lactam Antibiotics; Beta-Lactam Resistance; Bone Research; Drug Resistance; Drugs and Therapies; Glycopeptide Antibiotics; Glycopeptides Therapy; Health and Medicine; Infectious Bone Diseases and Conditions; Methicillin Resistance; Methicillin Therapy; Musculoskeletal Diseases and Conditions; Organic Chemicals; Osteomyelitis; Penicillin Resistance; Penicillins; Peptides; Pharmaceuticals; Quinolones Therapy; Sitafloxacin Therapy; Vancomycin Therapy EN Amides Antibacterials Antibiotics Antiinfectives Beta-Lactam Antibiotics Beta-Lactam Resistance Bone Research Drug Resistance Drugs and Therapies Glycopeptide Antibiotics Glycopeptides Therapy Health and Medicine Infectious Bone Diseases and Conditions Methicillin Resistance Methicillin Therapy Musculoskeletal Diseases and Conditions Organic Chemicals Osteomyelitis Penicillin Resistance Penicillins Peptides Pharmaceuticals Quinolones Therapy Sitafloxacin Therapy Vancomycin Therapy 3660 3660 1 11/06/23 20231110 NES 231110 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- A new study on osteomyelitis is now available. Keywords for this news article include: University of Rochester Medical Center, Antibacterials, Antiinfectives, Pharmaceuticals, Amides, Bone Research, Osteomyelitis, Drug Resistance, Organic Chemicals, Quinolones Therapy, Vancomycin Therapy, Drugs and Therapies, Health and Medicine, Methicillin Therapy, Sitafloxacin Therapy, Glycopeptides Therapy, Penicillin Resistance, Beta-Lactam Resistance. Taken together these studies demonstrate that HBCS adjuvant with standard of care debridement and vancomycin therapy has the potential to eradicate MRSA osteomyelitis.". [Extracted from the article]

We then demonstrate in silico that the construction of a dual biosensor-killer plasmid, which holds two genetical modules known as biosensor and bacteriocin modules, enables the recombinant host to sense QS molecules from MRSA. Keywords: Nuevo Leon; Mexico; North and Central America; Amides; Antibiotics; Bacillales; Bacteriocins; Beta-Lactam Antibiotics; Beta-Lactam Resistance; Biosensors; Biotechnology; Drug Resistance; Drugs and Therapies; Endospore-Forming Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Gram-Positive Endospore-Forming Rods; Health and Medicine; Membrane Proteins; Methicillin Resistance; Methicillin Therapy; Nanotechnology; Organic Chemicals; Penicillin Resistance; Penicillins; Pharmaceuticals; Pore Forming Cytotoxic Proteins; Staphylococcaceae; Staphylococcus; Staphylococcus aureus EN Nuevo Leon Mexico North and Central America Amides Antibiotics Bacillales Bacteriocins Beta-Lactam Antibiotics Beta-Lactam Resistance Biosensors Biotechnology Drug Resistance Drugs and Therapies Endospore-Forming Bacteria Gram-Positive Bacteria Gram-Positive Cocci Gram-Positive Endospore-Forming Rods Health and Medicine Membrane Proteins Methicillin Resistance Methicillin Therapy Nanotechnology Organic Chemicals Penicillin Resistance Penicillins Pharmaceuticals Pore Forming Cytotoxic Proteins Staphylococcaceae Staphylococcus Staphylococcus aureus 2258 2258 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Biosensors. [Extracted from the article]

Keywords: Cairo; Egypt; Africa; Amides; Antibacterials; Antibiotics; Antiinfectives; Bacillales; Beta-Lactam Antibiotics; Beta-Lactam Resistance; Biotechnology; Ciprofloxacin Therapy; Drug Delivery Systems; Drug Resistance; Drugs and Therapies; Endospore-Forming Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Gram-Positive Endospore-Forming Rods; Health and Medicine; Liposomes; Methicillin Resistance; Methicillin Therapy; Ophthalmic Antiinfectives; Ophthalmic Preparations; Organic Chemicals; Otic Antiinfectives; Otic Preparations; Penicillin Resistance; Penicillins; Pharmaceuticals; Quinolones Therapy; Staphylococcaceae; Staphylococcus; Staphylococcus aureus EN Cairo Egypt Africa Amides Antibacterials Antibiotics Antiinfectives Bacillales Beta-Lactam Antibiotics Beta-Lactam Resistance Biotechnology Ciprofloxacin Therapy Drug Delivery Systems Drug Resistance Drugs and Therapies Endospore-Forming Bacteria Gram-Positive Bacteria Gram-Positive Cocci Gram-Positive Endospore-Forming Rods Health and Medicine Liposomes Methicillin Resistance Methicillin Therapy Ophthalmic Antiinfectives Ophthalmic Preparations Organic Chemicals Otic Antiinfectives Otic Preparations Penicillin Resistance Penicillins Pharmaceuticals Quinolones Therapy Staphylococcaceae Staphylococcus Staphylococcus aureus 2203 2203 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on Biotechnology - Liposomes is the subject of a report. [Extracted from the article]

Amides, Antibiotics, Antiinfectives, Bacillales, Beta-Lactam Antibiotics, Drug Resistance, Drugs and Therapies, Endospore-Forming Bacteria, Enzymes and Coenzymes, Gram-Positive Bacteria, Gram-Positive Cocci, Gram-Positive Endospore-Forming Rods, Health and Medicine, Hospitals, Lactamase, Methicillin Resistance, Methicillin Therapy, Natural Penicillins, Beta-Lactam Resistance, Organic Chemicals, Penicillin Resistance, Penicillin Therapy, Penicillins, Pharmaceuticals, Staphylococcaceae, Staphylococcus, Staphylococcus epidermidis Keywords: Amides; Antibiotics; Antiinfectives; Bacillales; Beta-Lactam Antibiotics; Beta-Lactam Resistance; Drug Resistance; Drugs and Therapies; Endospore-Forming Bacteria; Enzymes and Coenzymes; Gram-Positive Bacteria; Gram-Positive Cocci; Gram-Positive Endospore-Forming Rods; Health and Medicine; Hospitals; Lactamase; Methicillin Resistance; Methicillin Therapy; Natural Penicillins; Organic Chemicals; Penicillin Resistance; Penicillin Therapy; Penicillins; Pharmaceuticals; Staphylococcaceae; Staphylococcus; Staphylococcus epidermidis EN Amides Antibiotics Antiinfectives Bacillales Beta-Lactam Antibiotics Beta-Lactam Resistance Drug Resistance Drugs and Therapies Endospore-Forming Bacteria Enzymes and Coenzymes Gram-Positive Bacteria Gram-Positive Cocci Gram-Positive Endospore-Forming Rods Health and Medicine Hospitals Lactamase Methicillin Resistance Methicillin Therapy Natural Penicillins Organic Chemicals Penicillin Resistance Penicillin Therapy Penicillins Pharmaceuticals Staphylococcaceae Staphylococcus Staphylococcus epidermidis 2209 2209 1 10/30/23 20231030 NES 231030 2023 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators publish new report on Staphylococcus epidermidis. [Extracted from the article]